Fraunhofer Researchers are developing a camera-based system that automatically records the spatial position and angle of ultrasound scans on the patient’s body.

The system enables continuous, real-time quality assurance of 3D cell production in bioreactors for biotech and pharmaceutical manufacturing.

Fraunhofer IPMS is collaborating with research and industry partners to develop state-of-the-art optoelectronic sensor technologies.

Researchers created silver-doped porous titanium surfaces using micro-arc oxidation, enabling rapid antibiotic loading and controlled release to reduce post-surgical infections.

Fraunhofer IPMS unveils a new EdgeVision Microdisplay technology improving efficiency and quality in high-resolution microdisplay production, with results showcased at the SID-MEC Conference, from November 3 to 4, 2025, in Göttingen.

Innovative polymer stent with patented protein coating promotes rapid endothelialisation, reduces lifelong anticoagulant use, restores vessel flexibility, and earned 2025 Innovation Award.

Fraunhofer IPMS introduces ultra-miniaturized MEMS-based microscan module, >98% reflectivity, operational at electronicaINDIA 2025, Bangalore, September 17–19.

Fraunhofer and University Hospital Würzburg collaborate to develop next-generation CAR T cells targeting RORs on solid tumors, using the Sleeping Beauty enzyme to simplify safe, efficient, and cost-effective production.

Fraunhofer’s NGS-based blood test detects pancreatic cancer early via DNA methylation analysis, distinguishing tumor types and stages with high accuracy.

Fraunhofer researchers are developing a hybrid X-ray and radar imaging system to diagnose cancer accurately while significantly reducing patient radiation exposure.